![]()
|
|
||||||||
q Coupling
Selectivity*
(Received for publication, May 20, 1997, and in revised form, July 14, 1997)

From the Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, Maryland 20892
Many different G protein-linked receptors are
preferentially coupled to G proteins of the Gq/11
family. To elucidate the molecular basis underlying this selectivity,
different Gq/11-coupled receptors (m3 muscarinic, V1a
vasopressin, and gastrin-releasing peptide receptor) were coexpressed
(in COS-7 cells) with mutant
s subunits in which
residues present at the C terminus of
s were replaced with the corresponding
q/11 residues. Remarkably,
whereas none of the receptors was able to interact with wild type
s to a significant extent, all three receptors gained
the ability to productively couple to a mutant
s subunit
containing a single Glu
Asn point mutation at position
3.
Moreover, the m3 muscarinic and the V1a vasopressin receptors but not
the GRP receptor also gained the ability to interact with a mutant
s subunit containing a single Gln
Glu point mutation
at position
5, indicating that the
q/11 residues
present in these mutant G protein constructs play key roles in
determining the selectivity of receptor recognition.
To identify the site(s) on Gq/11-coupled receptors that can
functionally interact with the C terminus of
q/11
subunits, we next analyzed the ability of a series of hybrid m2/m3
muscarinic receptors to interact with a mutant
s subunit
(sq5) in which the last five amino acids
of
s were replaced with the corresponding
q/11 sequence. Similar to the wild type m2 and m3
muscarinic receptors, none of the investigated hybrid receptors was
able to efficiently interact with wild type
s.
Interestingly, however, three mutant m2 receptors in which different
segments of the second and third intracellular loops were replaced with
the corresponding m3 receptor sequences were identified, which, in
contrast to the Gi/o-coupled wild type m2 receptor, gained
the ability to efficiently activate the sq5 subunit. This observation
suggests that multiple intracellular receptor domains form a binding
pocket for the C terminus of G protein
q/11
subunits.
Upon binding of extracellular ligands, G protein-coupled receptors
(GPCRs)1 undergo conformational changes that enable the
receptor proteins to interact with specific classes of heterotrimeric G
proteins consisting of
,
, and
subunits (1-7). The activated
G protein subunits (
-GTP and/or free 
) are then able to bind
to and modulate the activity of downstream effector enzymes and/or ion
channels. Typically, an individual GPCR can interact with only a
distinct subset of the many structurally similar G proteins that are
expressed within a cell (1-7). How this selectivity is achieved at a
molecular level is not well understood at present, particularly since
the molecular architecture of the receptor·G protein complex has not been elucidated.
Numerous mutagenesis and biochemical studies (1-7) have shown that multiple intracellular GPCR domains, primarily including the second intracellular loop (i2) as well as the N- and C-terminal portions of the third intracellular loop (i3), play key roles in determining selective G protein recognition. Specific residues contained within these domains are predicted to form a binding pocket for the G protein heterotrimer (7), in analogy to the ligand binding domain present on the extracellular surface of GPCRs (1, 2, 4, 6).
Accumulating evidence (8-11) suggests that the C-terminal portion of
the G protein
subunits, via binding to the intracellular receptor
surface (12, 13), is of fundamental importance for dictating the
specificity of receptor-G protein interactions. Several recent studies
(8-11) have shown, for example, that substitution of
i
or
s residues into the C-terminal segment of
q subunits results in mutant G proteins that can be
activated by Gi- or Gs-coupled receptors,
respectively. By taking advantage of this observation, the C-terminal
amino acids in
i/o subunits that are critical for
proper receptor recognition have been mapped in great detail (11). In
contrast, the functional roles of individual amino acids present at the
C termini of other classes of G
subunits have not been studied
systematically to date.
To identify the site(s) on GPCRs that can functionally interact with
the C terminus of
i/o subunits, we have recently used a
novel experimental strategy involving the coexpression of hybrid receptors with hybrid G
subunits. We initially showed that the wild
type m2 muscarinic receptor, a prototypical Gi/o-coupled receptor (14-16), does not efficiently interact with wild type
q but can productively couple to mutant
q
subunits in which the last five amino acids of
q were
replaced with the corresponding
i or
o
sequences (9). We then demonstrated, by analyzing a large number of
mutant m2 receptors, that the ability of the m2 receptor to interact
with such hybrid
q subunits was critically dependent on
the structural integrity of a four-amino acid motif (VTIL;
Val385, Thr386, Ile389, and
Leu390) predicted to be located at the C terminus of the i3
loop (9, 11). In addition, gain-of-function studies showed that
substitution of the VTIL motif into mutant m3 muscarinic receptors
(which were unable to couple to wild type
q) could
confer onto these receptors the ability to efficiently couple to mutant
q containing
i or
o
sequences at their C terminus (9). These data therefore suggested that
the VTIL motif can functionally interact with the C terminus of
i/o subunits and that this contact is intimately involved in determining coupling selectivity and triggering G protein
activation.
To investigate whether the results obtained with the
Gi/o-coupled m2 muscarinic receptor are generally
applicable, we recently have extended these studies to other functional
classes of GPCRs and G
subunits. In the present study, we first
wanted to examine which specific amino acids present at the C terminus
of
q/11 subunits are of particular importance for
selective receptor recognition. Toward this goal, we systematically
substituted distinct
q/11 residues into the C terminus
of
s (a G protein subunit that mediates the activation
of adenylyl cyclase) and studied whether the resulting mutant
subunits gained the ability to be activated by different Gq/11-coupled receptors. Remarkably, two
q/11 residues were identified which, when substituted
into wild type
s, resulted in
s single point mutants that, in contrast to wild type
s, could be
recognized by Gq/11-coupled receptors.
The second goal of this study was to identify the site(s) on
Gq/11-coupled receptors that can functionally interact with
the C terminus of
q/11 subunits. To address this issue,
we took advantage of the finding that the Gi/o-coupled m2
muscarinic receptor, in contrast to the Gq/11-coupled m3
muscarinic receptor (15, 16), cannot functionally interact with a
mutant
s subunit containing
q sequence at
its C terminus. Based on this observation, mutant m2 muscarinic
receptors in which distinct intracellular domains were replaced with
the corresponding m3 receptor sequences were studied for their ability
to gain coupling to this mutant
subunit. These coexpression
experiments led to the novel finding that multiple m3 receptor regions,
including residues within the i2 loop and the N- and C-terminal
portions of the i3 domain, are critical for selective recognition of
the C terminus of
q/11 subunits.
A rat
s cDNA (17) cloned
into the pcDNAI expression vector (10) was used as a template for
PCR mutagenesis. All wild type and mutant G
s subunits
contained an internal hemagglutinin epitope tag (DVPDYAS; Refs. 18 and
19). The presence of the epitope tag that replaced
s
residues 76-82 did not affect the receptor and effector coupling
properties of wild type
s (18, 19). The construction of
sq5 (which codes for a mutant
s subunit in which the
last five amino acids of
s were replaced with the corresponding
q sequence) has been described previously
(10). To introduce mutations into the C-terminal segment of
s, a 42-base pair NsiI-XbaI
fragment was removed from the wild type plasmid and replaced with PCR
fragments containing the desired mutations. The correctness of all
PCR-derived sequences was verified by dideoxy sequencing of the mutant
plasmids (20).
The construction of the hybrid m2/m3 muscarinic receptors used in this
study has been described previously (Refs. 21-23; for precise amino
acid compositions, see legend to Fig. 4).
m3164-183), m2-Ni3 (m2208-228
m3252-272), m2-Y (m2-Ser210
m3-Tyr254), m2-AALS
(m2-Val385-Thr386,
Ile389-Leu390
m3-Ala488-Ala489,
Leu492-Ser493), and m2-tail
(m2401-466
m3504-589).
Cell Culture and Transfection Conditions
COS-7 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum at 37 °C in a humidified 5% CO2 incubator. For transfections, 1 × 106 cells were seeded into 100-mm dishes. About 24 h later, COS-7 cells were cotransfected with the indicated G protein and receptor constructs (0.8 µg of DNA each) by using a DEAE-dextran procedure (24). To reduce the expression levels of the different receptor and G protein constructs, transfection mixtures were supplemented with 2.4 µg of pcDNAI vector DNA. The following wild type receptor expression plasmids were used: human m2 muscarinic receptor in pcD (25), rat m3 muscarinic receptor in pcD (25), mouse gastrin-releasing peptide (GRP) receptor (26) in pcDNA3 (kindly provided by J. Battey, NIH), and rat V1a vasopressin receptor (27) in pcD-SP6/T7 (kindly provided by M. Brownstein, NIH).
cAMP AssaysApproximately 20-24 h after transfections, cells were transferred into six-well plates, and 2 µCi/ml [3H]adenine (15 Ci/mmol; American Radiolabeled Chemicals) was added to the growth medium. After a 24-36 h labeling period, cells were preincubated in Hanks' balanced salt solution containing 20 mM Hepes and 1 mM 3-isobutyl-1-methylxanthine for 20 min (room temperature) and then stimulated with the appropriate agonist ligands for 30 min at 37 °C. The reaction was terminated by aspiration of the medium and addition of 1 ml of ice-cold 5% trichloroacetic acid containing 1 mM ATP and 1 mM cAMP. Increases in intracellular [3H]cAMP levels were then determined by anion-exchange chromatography as described (28).
Radioligand Binding AssaysN-[3H]Methylscopolamine (79.5 Ci/mmol; NEN Life Science Products) saturation binding experiments were carried out with membrane homogenates prepared from transfected COS-7 cells essentially as described (29). Nonspecific binding was determined in the presence of 1 µM atropine. Protein concentrations were determined by the method of Bradford (30). Binding data were analyzed by using the computer program Ligand (31).
Western BlottingAll wild type and mutant G
s
subunits were detected with the 12CA5 monoclonal antibody (Boehringer
Mannheim) directed against the hemagglutinin epitope tag present in all
G protein constructs. Samples containing 20 µg of membrane protein
prepared from transfected COS-7 cells were resolved by
SDS-polyacrylamide gel electrophoresis (10%), electroblotted onto
nitrocellulose, and probed with the 12CA5 antibody as described (9).
Immunoreactive proteins were detected by incubation with horseradish
peroxidase-conjugated sheep anti-mouse antibody (Amersham Life Science,
Inc.) and visualized using an enhanced chemiluminescence system
(Amersham).
[Arg8]Vasopressin was purchased from Sigma. All other ligands used in this study were obtained through Research Biochemicals Inc.
s Subunits
All studies were carried out
with COS-7 cells cotransfected with different GPCRs and G
constructs. Initially, the ability of the rat m3 muscarinic receptor
(25), a prototypical Gq/11-coupled receptor (15, 16), to
interact with wild type
s (s(wt)) was examined. As
expected, based on its known G protein coupling preference, the m3
muscarinic receptor, when cotransfected with s(wt) (or vector DNA as a
control) and stimulated with the agonist carbachol (500 µM), did not efficiently stimulate cAMP production. The
maximum increase in cAMP accumulation (above basal levels) mediated by the m3 receptor in the absence or presence of cotransfected s(wt) amounted to only 1.5-2-fold (see Fig. 2A). However,
coexpression of the m3 muscarinic receptor with a mutant
s subunit in which the last five amino acids (QYELL)
were replaced with the corresponding
q sequence (EYNLV;
resulting in the hybrid
subunit, sq5) led to a pronounced
stimulation (6-8-fold) of adenylyl cyclase activity (see Fig.
2A). Essentially similar results were obtained with two
other Gq/11-coupled receptors, the rat V1a vasopressin (27) and the mouse GRP receptor (26). Like the m3 receptor, these two
peptide receptors, when activated by the appropriate agonist ligands
([Arg8]vasopressin (1 µM) and bombesin (1 µM)), did not couple efficiently to s(wt) (see Figs. 2,
B and C). In contrast, both peptide receptors were able to productively interact with sq5, mediating 4-8-fold increases in cAMP levels in the presence of this G protein subunit (see
Figs. 2, B and C).
s subunits. COS-7 cells were cotransfected with
expression plasmids coding for the wild type m3 muscarinic
(A), V1a vasopressin (B), or GRP (C)
receptor and the indicated G protein constructs (or pCDNAI vector
DNA as a control). The structure of the different mutant
s subunits, in which one or more amino acids at the C
terminus of s(wt) were replaced with the corresponding
q/11 residues, is shown in Fig. 1. In sq5, the last five
amino acids of s(wt) were replaced with the corresponding
q sequence. Transfected cells were incubated for 30 min
(at 37 °C) in the absence or presence of the appropriate agonist
ligands. Basal cAMP levels (no ligand added) were similar for the
different wild type and mutant G protein constructs (data not shown).
The resulting increases in intracellular cAMP levels (fold stimulation
above basal) were determined as described under "Experimental
Procedures." In each experiment, the cAMP response mediated by sq5
was set equal to 100%. Data are given as means ± S.E. of three
to eight independent experiments, each carried out in triplicate. The
following ligands were used: A, carbachol (500 µM); B, [Arg8]vasopressin (1 µM); C, bombesin (1 µM).
We next wanted to examine which specific amino acids within the
C-terminal segment of
q/11 are of particular importance
for proper receptor recognition. Toward this goal, specific residues at
the C terminus of s(wt) were replaced either alone or in combination with the corresponding
q/11 residues (Fig.
1). The ability of different
Gq/11-coupled receptors to gain coupling to these mutant
s subunits was then examined in cotransfected COS-7
cells.
subunits. Mutant
s subunits were created by replacing the marked
s residues (arrows), either individually or
in combination, with the corresponding
q/11 residues.
The single-letter amino acid code is used. The boxed leucine
residue (position
2) is conserved among all known mammalian
subunits. Sequences were taken from Ref. 46.
As shown in Fig. 1, the C-terminal five amino acids of
s
differ in only three residues from the corresponding
q/11 sequence (the leucine residue at
position
2 is conserved among all mammalian
subunits, and a
tyrosine residue is present at position
4 in both
s
and
q/11). Therefore, three
s single
point mutants, s(Q
E), s(E
N), and s(QL
EV), and all three
possible
s double point mutants, s(QE
EN), s(EL
NV), and s(QL
EV), were prepared (Figs. 1 and
2). Western analysis using a monoclonal antibody directed against the hemagglutinin epitope tag present in all
G protein constructs (18, 19) showed that all mutant
s
subunits were expressed at similar levels as s(wt) and sq5 (Fig.
3).
s subunits expressed in COS-7 cells. Equal amounts
of membrane protein (20 µg) prepared from transfected COS-7 cells
were analyzed by SDS-polyacrylamide gel electrophoresis (10%) and
Western blotting using the 12CA5 monoclonal antibody as described under
"Experimental Procedures." Two additional blots gave similar
results.
Initially, the ability of the m3 muscarinic receptor to functionally
interact with the different mutant
s subunits was
examined (Fig. 2A). Remarkably, the m3 receptor gained the
ability to activate two
s single point mutants, s(Q
E) and s(E
N), to a significant extent. In the presence of
carbachol (500 µM) and either of these two subunits, the
m3 receptor was able to mediate a marked increase in adenylyl cyclase
activity ((4-5-fold, as compared with an 6-8-fold increase observed
with sq5) (Fig. 2A). In contrast, coexpression of the m3
muscarinic receptor with s(L
V) did not result in a cAMP response
that was significantly different from background (as determined
in cells transfected with either vector DNA or s(wt)) (Fig.
2A).
To examine whether the functional effects caused by the single amino
acid substitutions were additive, three
s double point mutants, s(QE
EN), s(EL
NV), and s(QL
EV), were constructed and functionally analyzed. When coexpressed with the m3 muscarinic receptor, s(QE
EN) was able to mediate a cAMP response that was
similar in magnitude to that observed with sq5 (Fig. 2A), indicating that the functional effects of the Q
E and E
N point
mutations were additive. In contrast, the s(EL
NV) and s(QL
EV)
double point mutants showed functional responses similar to those found
with s(E
N) and s(Q
E), respectively, suggesting that the
C-terminal amino acid of
q/11 is not critical for
receptor recognition.
To study whether the results obtained with the m3 muscarinic receptor
are also applicable to other Gq/11-coupled receptors, the
different G
s constructs were also coexpressed with the
V1a vasopressin and the GRP receptor. As shown in Fig. 2B,
the V1a vasopressin receptor showed a functional profile that was very similar to that found with the m3 muscarinic receptor. In contrast, the
activity pattern seen with the GRP peptide receptor differed somewhat
from that found with the two other receptors. Similar to the m3
muscarinic and V1a vasopressin receptors, the GRP receptor gained the
ability to activate s(E
N) (as well as the s(QE
EN) and s(EL
NV) double point mutants) and did not efficiently couple to s(L
V) (Fig. 2C). However, in contrast to the two other
receptors examined in this study, the GRP receptor did not interact to a significant extent with the s(Q
E) single point and
the s(QL
EV) double point mutants (Fig. 2C).
q/11
The second major goal of
this study was to identify the site(s) on Gq/11-coupled
receptors that can functionally interact with the C terminus of
q/11 subunits. To address this question, we employed a
gain-of-function mutagenesis approach, analyzing the ability of a
series of hybrid m2/m3 muscarinic receptors (Fig. 4) to interact with the mutant
s subunit, sq5, in which the last five amino acids of
s were replaced with the corresponding
q sequence. As shown in Fig. 5, the m2
muscarinic receptor, a prototypical Gi/o-coupled receptor,
did not activate either s(wt) or sq5 to a significant extent. We thus
hypothesized that substitution into the m2 receptor of the m3 receptor
domain(s) capable of recognizing the C terminus of
q
should enable the resulting hybrid receptor(s) to interact with the sq5
subunit. The m2-i2, m2-Ni3, m2-Y, and m2-AALS hybrid receptors (Fig. 4)
were included in this analysis because previous studies had shown that
the m3 receptor regions/residues contained in these constructs are
critical for efficient recognition of Gq/11 proteins (22,
23, 32, 33) (m2-tail was included as a negative control; see Refs. 21
and 23). N-[3H]Methylscopolamine saturation
binding studies showed that all hybrid receptors were expressed at
levels similar to those found with the m2 and m3 wild type receptors
(for Bmax values, see legend to Fig.
5).
s
subunit, sq5. COS-7 cells were cotransfected with the indicated
receptor constructs (for receptor structures and precise amino acid
compositions, see Fig. 3) and vector DNA (pCDNAI, control), s(wt),
or sq5. Cells were incubated for 30 min at 37 °C with 500 µM carbachol, and the resulting increases in
intracellular cAMP levels were determined as described under
"Experimental Procedures." Data are presented as fold increase in
cAMP above basal levels in the absence of carbachol. Basal cAMP levels
for the wild type m3 muscarinic receptor cotransfected with s(wt)
amounted to 800 ± 150 cpm/well. The basal cAMP levels observed
with all other receptor constructs were not significantly different
from this value. Also, basal cAMP levels found with cells cotransfected
with sq5 were similar to the corresponding s(wt) values. Data are given
as means ± S.E. of three independent experiments, each carried
out in triplicate. N-[3H]Methylscopolamine
saturation binding studies gave the following Bmax values (fmol/mg membrane protein;
n = 3): m2(wt) (293 ± 17), m3(wt) (284 ± 5), m2-i2 (192 ± 23), m2-Ni3 (297 ± 18), m2-Y (315 ± 54), m2-AALS (324 ± 40), and m2-tail (409 ± 27).
Interestingly, three of the investigated hybrid receptors, m2-i2,
m2-Ni3, and m2-AALS, gained the ability to productively interact with
the sq5 mutant subunit, mediating 4-6-fold increases in cAMP
production (Fig. 5). In contrast, none of these hybrid receptors was
able to efficiently interact with s(wt). In these constructs, the i2
loop, the first 21 amino acids of the i3 domain, and a four-amino acid
motif (AALS; Ala488, Ala489,
Leu492, and Ser493) at the C terminus of the i3
loop were derived from the m3 muscarinic receptor. The m2-Y mutant
receptor (which contains a Ser210
Tyr point mutation at
the N terminus of the i3 loop) and the m2-tail construct (in which the
last 66 amino acids of the m2 receptor were replaced with the
corresponding m3 receptor sequence) showed a functional profile similar
to that of the wild type m2 muscarinic receptor.
The
subunits of heterotrimeric G proteins are known to play
central roles in receptor-G protein and G protein-effector interactions (3, 5). Whereas more centrally located loop and helical domains of G
are known to be involved in effector binding, considerable evidence
suggests that the C-terminal segment of G
can directly contact the
receptor protein (3, 5). Consistent with this notion, high resolution
crystal structures (34, 35) suggest that the C terminus of G
subunits is surface-exposed and thus easily accessible for interactions
with the receptor. In addition, several recent studies (8-11) show
that the C-terminal portion of G
subunits also plays a key role in
dictating the specificity of receptor-G protein coupling. It could be
demonstrated (8, 9) for example that mutant versions of
q (a subunit that can activate various isoforms of
phospholipase C-
) in which the last five amino acids of
q replaced with the corresponding
i/o
sequences allowed stimulation of phospholipase C-
by receptors (A1
adenosine, D2 dopamine, and m2 muscarinic receptors) that otherwise are
exclusively coupled to G proteins of the Gi/o class which
cannot activate phospholipase C-
efficiently. Subsequently, by
studying the ability of the Gi/o-coupled m2 muscarinic
receptor to activate mutant
q subunits containing single
C-terminal
i residues, the functional roles of
individual amino acids present at the C terminus of
i/o subunits have been defined (11).
Whereas the structural characteristics of the C-terminal domain of
subunits of the
i/o protein family (including
-transducin) have been analyzed in great detail (36-39), little is
known about the functional roles of the corresponding amino acids
present in other classes of G
subunits. One goal of the present
study therefore was to examine which specific amino acids present at the extreme C terminus of G proteins of the
q/11 family
are involved in proper receptor recognition. To address this question,
we employed a gain-of-function mutagenesis approach involving the
coexpression of different Gq/11-coupled receptors
with mutant
s subunits containing distinct
q/11 residues at their C termini. Consistent with the results of a previous study (10), we initially demonstrated that the m3
muscarinic, the V1a vasopressin, and the GRP receptors (which are all
prototypical Gq/11-coupled receptors) do not couple efficiently to wild type
s but can productively interact
with a mutant
s subunit (sq5) in which the last five
amino acids of
s were replaced with the corresponding
q/11 sequence.
Since the C-terminal five amino acids of
s differ in
only three residues from the corresponding
q/11 sequence
(Fig. 1), three
s single point mutants (s(Q
E), s(E
N), and s(L
V)) were prepared and functionally analyzed.
Whereas none of the tested Gq/11-coupled receptors was able
to activate the s(L
V) subunit, all of them gained the ability to
productively interact with the s(E
N) single point mutant. Two of
the receptors (m3 muscarinic and V1a vasopressin) were also capable of
activating the s(Q
E) subunit. These two receptors were able to
interact with the s(QE
EN) double point mutant with greater
efficacy than observed with the s(Q
E) and s(E
N) single point
mutants, mimicking quantitatively the functional activity of the sq5
subunit. Taken together, these gain-of-function experiments strongly
suggest that two C-terminal
q/11 residues, an asparagine
at position
3 and a glutamate at position
5, play key roles in
determining the receptor selectivity of G protein
q/11
subunits. Consistent with this notion, these two residues are found,
with no exception, in all members of the
q/11 protein
family (
q,
11,
14,
15, and
16; Fig. 1).
Interestingly, molecular genetic and biochemical studies (11, 36-38)
show that the C-terminal residues of subunits of the
i/o
protein family, which dictate the specificity of receptor recognition,
are present at positions
4 (cysteine),
3 (glycine), and
1
(phenylalanine/tyrosine) (Fig. 1). Thus, the precise positions of the
C-terminal amino acids that are critical for determining the
specificity of receptor-G protein interactions differ between different
functional classes of G
subunits. However, in both
i/o and
q/11 subunits, the residue
present at the
3 position is of critical importance for receptor-G
protein coupling selectivity. As shown in Fig. 1, the residues present
at this position are perfectly conserved within individual G
subfamilies and can correctly predict the coupling profile of a given
G
subunit. It is therefore likely that the corresponding residues in
s and
12/13 (glutamate and methionine,
respectively) have a similar functional importance as the glycine and
asparagine residues present at
3 position of
i/o and
q/11 subunits, respectively. This, however, remains to
be tested experimentally.
In the crystal structures of two G protein heterotrimers, the
C-terminal segment of G
was disordered and not visible (34, 35).
However, NMR studies on a C-terminal
-transducin peptide suggest
that the last four amino acids of
i/o subunits form a type II
-turn (which depends on the presence of the conserved glycine residue at
3 position) that is broken upon interaction with
the ligand-occupied receptor (39). Dratz et al. (39) therefore speculated that different types of
-turn at the extreme C
terminus of G
subunits are critical for determining the selectivity of receptor recognition. It is possible that the asparagine side chain
present at
3 position in
q/11 subunits is able to
hydrogen bond back to the main chain, thus forming a type VIII
-turn
characterized by a spatial arrangement of the C-terminal amino acids
which differs from that found with
i/o subunits
(39).
To gain deeper insight into the molecular mechanisms governing
receptor-G protein interactions and G protein activation, the receptor
site that interacts with the extreme C terminus of G
needs to be
identified. By using a coexpression strategy analogous to that
described here, we could previously show that the C terminus of
i/o subunits can contact a four-amino acid motif on the
m2 muscarinic receptor (VTIL; Val385, Thr386,
Ile389, and Leu390) predicted to be located at
the C terminus of the i3 loop (9, 11). Since these residues are located
in a region that is thought to be
-helically arranged (23, 40-42),
the VTIL motif is predicted to form a hydrophobic surface that is
critical for G protein recognition.
To examine whether this receptor-G
contact site is also conserved
among other functional classes of GPCRs and G proteins, the second
major goal of the present study was to map the site(s) on
Gq/11-coupled receptors that is (are) recognized by the C
terminus of
q/11 subunits. We initially showed that
neither the wild type m2 nor the wild type m3 muscarinic receptor,
consistent with their known G protein coupling preference for
Gi/o and Gq/11 proteins, respectively, can
efficiently interact with wild type
s. Whereas the m3
muscarinic receptor gained the ability to interact with the chimeric
s/
q subunit, sq5, the m2 muscarinic
receptor was unable to interact with this mutant subunit. We therefore
speculated that substitution into the m2 muscarinic receptor of the m3
receptor region(s) which can recognize the C terminus of
q/11 subunits should confer on the resulting hybrid
receptor(s) the ability to activate sq5. Consistent with this concept,
we found that a mutant m2 muscarinic receptor, m2-AALS (Figs. 4 and 5),
in which the VTIL motif was replaced with the corresponding m3 receptor residues (Ala488, Ala489, Leu492,
and Ser493, respectively) gained the ability to
functionally interact with the sq5 subunit. This observation suggests
that the VTIL/AALS residues define a conserved GPCR site that is
generally involved in the recognition of the C terminus of G
subunits.
Interestingly, however, functional analysis of additional m2/m3 hybrid receptors showed that the m2-AALS construct was not the only mutant receptor capable of activating sq5. Two additional m2 mutant receptors, m2-i2 and m2-Ni3 (Figs. 4, 5), were identified that showed a functional profile very similar to that of m2-AALS. In these two mutant receptors, the i2 loop and the N-terminal portion of the i3 loop, respectively, were replaced with the corresponding m3 receptor sequences. Previous studies have shown that these two domains, together with the AALS motif present at the C terminus of the i3 loop, are critical for selective recognition of Gq/11 proteins by the m3 muscarinic receptor (23, 33).
One possible explanation for the observed ability of multiple m2/m3
hybrid receptors to activate the chimeric
s/
q subunit, sq5, is that the C terminus
of
q/11 subunits can be contacted by multiple m3
receptor regions. Based on detailed site-directed mutagenesis studies
(33) and several theoretical considerations (43), we recently proposed
a model of the intracellular m3 receptor surface in which the
functionally critical receptor residues present in the i2 loop and at
the N and C terminus of the i3 domain all project into the interior of
the receptor protein, thus forming a well defined G protein binding
pocket (Fig. 6), analogous to the ligand
binding site present on the extracellular receptor surface. It is
therefore conceivable that the C-terminal portion of the G
subunits,
by binding to this intracellular receptor "cavity," can interact
with multiple receptor sites that lie adjacent to each other in the
properly folded receptor protein.
-helical extensions of transmembrane helices V and VI (23, 40-42)
are depicted. The highlighted residues at the N and C terminus of
the i3 loop are predicted to form two hydrophobic patches, which,
together with several hydrophilic residues in the i2 loop, are critical
for proper G protein recognition (modified according to Ref. 7).
As indicated above, we previously identified only one major receptor
contact site for the C terminus of
i/o subunits by using a coexpression strategy analogous to that described here (9). One
possible reason for the discrepancy between this finding and the
results of the present study is that the relative functional importance
of the i2 loop and the N- and C-terminal segments of the i3 domain may
differ among different receptor-G
pairs. Alternatively, it is
possible that the assay system employed in this study was more
sensitive than the one used previously. In the present study, neither
of the two wild type nor the different m2/m3 hybrid receptors were able
to couple to wild type
s, thus allowing for a
straightforward interpretation of the coexpression experiments
involving the chimeric G
subunit, sq5. In contrast, the
interpretation of our previous mutagenesis data was complicated by the
fact that several of the analyzed m2/m3 hybrid receptors gained some
degree of coupling to wild type
q (which served as
template for introducing C-terminal
i residues) and were
therefore able to activate phospholipase C-
even in the absence of
coexpressed hybrid
q/
i subunits (9).
The conclusion drawn from these gain-of-function mutagenesis
experiments that the C terminus of G
subunits can be contacted by
several different receptor sites is also supported by a recent loss-of-function study (44) examining the ability of an 11-amino acid
peptide derived from the C terminus of
-transducin to bind to wild
type and mutant versions of rhodopsin. This peptide, via direct binding
to rhodopsin (12, 39), can stabilize the active metarhodopsin II state
and can uncouple rhodopsin-transducin interactions. However, these
effects were no longer observed when the peptide was incubated with
mutant rhodopsins containing multiple mutations in the i2 loop and at
the C terminus of the i3 domain, suggesting that the C terminus of
-transducin is recognized by at least two different receptor sites
(44).
Although the present study again highlights the key role of the C
terminus of G
subunits in proper receptor recognition, considerable
evidence suggests that other domains on the G
subunits as well as
the G protein 
complex can also modulate the selectivity of
receptor-G protein interactions, most likely by directly contacting the
receptor protein (5, 45). The GPCR sites involved in these interactions
remain to be identified.
In conclusion, we have shown for the first time that the coupling
specificity of G
s can be changed by single amino acid
substitutions (
s
q), leading to the
identification of two C-terminal
q/11 residues that are
critical for proper receptor recognition. Moreover, our
gain-of-function mutagenesis data predict that multiple intracellular receptor domains form a binding pocket for the C-terminal segment of
q/11 subunits. By using a coexpression strategy similar
to that described here, it should be possible to map other functionally relevant receptor-G protein contact sites. The information gathered from such studies should eventually lead to a refined model of the
receptor-G protein interface.
To whom correspondence should be addressed: Laboratory of
Bioorganic Chemistry, NIDDK, National Institutes of Health, Bldg. 8A,
Rm. B1A-05, Bethesda, Maryland 20892. Tel.: 301-402-3589; Fax:
301-402-4182.
s in which the
last five amino acids were replaced with the corresponding
q sequence; i2 and i3, the second and third
intracellular loops of G protein-coupled receptors, respectively; PCR,
polymerase chain reaction; GRP, gastrin-releasing peptide; s(wt), wild
type G
s.
We thank Drs. B. Conklin, J. Battey, and M. Brownstein for generously providing us with receptor or G protein expression plasmids.
This article has been cited by other articles:
![]() |
M. L. Matsumoto, K. Narzinski, G. V. Nikiforovich, and T. J. Baranski A Comprehensive Structure-Function Map of the Intracellular Surface of the Human C5a Receptor: II. ELUCIDATION OF G PROTEIN SPECIFICITY DETERMINANTS J. Biol. Chem., February 2, 2007; 282(5): 3122 - 3133. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Michal, E. E. El-Fakahany, and V. Dolezal Muscarinic M2 Receptors Directly Activate Gq/11 and Gs G-Proteins J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 607 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Langer, C. Langlet, and P. Robberecht Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor J. Mol. Endocrinol., April 1, 2005; 34(2): 405 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kostenis, L. Martini, J. Ellis, M. Waldhoer, A. Heydorn, M. M. Rosenkilde, P. K. Norregaard, R. Jorgensen, J. L. Whistler, and G. Milligan A Highly Conserved Glycine within Linker I and the Extreme C Terminus of G Protein {alpha} Subunits Interact Cooperatively in Switching G Protein-Coupled Receptor-to-Effector Specificity J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugimoto, T. Nakato, A. Kita, Y. Takahashi, N. Hatae, H. Tabata, S. Tanaka, and A. Ichikawa A Cluster of Aromatic Amino Acids in the i2 Loop Plays a Key Role for Gs Coupling in Prostaglandin EP2 and EP3 Receptors J. Biol. Chem., March 19, 2004; 279(12): 11016 - 11026. [Abstract] [Full Text] [PDF] |
||||
![]() |
|